1 jan 2003 ano - NCI-Sponsored Prostate Cancer Prevention Trial (PCPT)
Descrição:
Results of the NCI-sponsored Prostate Cancer Prevention Trial (PCPT) show that the drug finasteride, which decreases male hormone production in the body, reduces a man's risk of prostate cancer by about 25%.
Adicionado na linha do tempo:
Data: